Teleflex Inc. (TFX) Receives Consensus Rating of “Buy” from Brokerages
Shares of Teleflex Inc. (NYSE:TFX) have been assigned a consensus recommendation of “Buy” from the ten ratings firms that are covering the stock. Two equities research analysts have rated the stock with a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $173.38.
Several research firms have commented on TFX. Barclays PLC upped their price objective on shares of Teleflex from $183.00 to $185.00 and gave the company an “overweight” rating in a report on Friday, July 29th. Jefferies Group upped their price target on Teleflex from $157.00 to $185.00 and gave the company a “hold” rating in a research report on Friday, July 29th. Leerink Swann upped their price target on Teleflex from $183.00 to $190.00 and gave the company a “market perform” rating in a research report on Friday, July 29th. Finally, Zacks Investment Research upgraded Teleflex from a “hold” rating to a “buy” rating and set a $192.00 price target on the stock in a research report on Wednesday, June 29th.
Shares of Teleflex (NYSE:TFX) traded up 0.77% during trading on Thursday, hitting $166.64. 103,450 shares of the stock traded hands. Teleflex has a 1-year low of $123.79 and a 1-year high of $188.79. The stock has a market cap of $7.34 billion, a price-to-earnings ratio of 29.58 and a beta of 0.83. The stock has a 50 day moving average price of $175.50 and a 200-day moving average price of $170.45.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/13/teleflex-inc-tfx-receives-consensus-rating-of-buy-from-brokerages.html
Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, July 28th. The medical technology company reported $1.89 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.15. The business had revenue of $473.60 million for the quarter, compared to the consensus estimate of $468.40 million. Teleflex had a net margin of 14.89% and a return on equity of 15.59%. The company’s revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.42 earnings per share. Equities analysts forecast that Teleflex will post $7.33 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 15th. Investors of record on Monday, August 15th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.82%. The ex-dividend date of this dividend was Thursday, August 11th. Teleflex’s dividend payout ratio (DPR) is 24.11%.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Tower Research Capital LLC TRC purchased a new stake in shares of Teleflex during the second quarter valued at about $118,000. Huntington National Bank raised its stake in shares of Teleflex by 6.5% in the second quarter. Huntington National Bank now owns 820 shares of the medical technology company’s stock valued at $145,000 after buying an additional 50 shares in the last quarter. Checchi Capital Advisers LLC raised its stake in shares of Teleflex by 0.8% in the second quarter. Checchi Capital Advisers LLC now owns 837 shares of the medical technology company’s stock valued at $148,000 after buying an additional 7 shares in the last quarter. Welch & Forbes LLC purchased a new stake in shares of Teleflex during the second quarter valued at about $204,000. Finally, Broderick Brian C purchased a new stake in shares of Teleflex during the second quarter valued at about $207,000. Institutional investors own 93.77% of the company’s stock.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.
Receive News & Ratings for Teleflex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Inc. and related companies with MarketBeat.com's FREE daily email newsletter.